Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people […]
Related Posts
Gefällt mir: Ärzte auf Facebook
zum Lesen bitte auf den Artikel klicken:
New Treatment Options for Those With Atopic Dermatitis
If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults. Although many adults with atopic dermatitis (commonly known as eczema) develop th…
Verschluckte Fremdkörper bei Borderline-Syndrom
Kurze Fallbeschreibung: Pat weiblich 25 J. mit emonotial instabilen Persönlichkeitsstörung (Borderline-Syndrom) wird aus einer psychiatrischen Klinik wiederholt in der Notfallambulanz vorgestellt, weil sie aus inneren Spannungs und Druckgefühl unte…